Site Members can sign up for company wide alerts
Investigation Overview
April 1, 2016 (Shareholders Foundation) - An investigation on behalf of investors, who purchased shares ofValeant Pharmaceuticals Intl Inc (NYSE:VRX) in the March 18, 2015 Secondary Offering at $199.00 per share, was announced concerning over potential securities laws violations in connection with the March 18, 2015 Secondary Offering. Shares of Valeant Pharmaceuticals Intl Inc (NYSE:...
You must register (for free) or login to view the entire investigation.